HomeAI · summaries
Storia in 2 fonti
Indian generic drugmaker gets FDA warning over clinical study consent
Alembic Pharmaceuticals received an FDA warning letter for failing to label a bioequivalence study as
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Alembic site slapped with FDA warning letter over patient consent concerns
Following an inspection earlier this year that yielded a Form 483, Indian generics juggernaut Alembic Pharmaceuticals has received a harsher reprimand from the U.S. | Following an…
- ·
endpoints.news
Indian generic drugmaker gets FDA warning over clinical study consent
Alembic Pharmaceuticals received an FDA warning letter for failing to label a bioequivalence study as